Improving emotional control to lower suicide risk in individuals with psychosis
Targeting Emotion Dysregulation to Reduce Suicide in People with Psychosis
This study is testing a group program that teaches skills to help people with psychosis manage their emotions better, with the hope of reducing thoughts and feelings about suicide.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10915471 on NIH RePORTER |
What this research studies
This research focuses on individuals with psychosis who are at risk of suicide due to difficulties in managing their emotions. It aims to implement a group training program based on Dialectical Behavior Therapy (DBT) skills, which has been effective in helping others regulate their emotions. Participants will engage in a pilot trial to assess the effectiveness of this intervention in reducing suicidal thoughts and behaviors. By addressing emotion dysregulation, the study seeks to provide a targeted approach to suicide prevention in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with psychotic disorders who experience heightened suicidality and have difficulty regulating their emotions.
Not a fit: Patients who do not have a diagnosis of a psychotic disorder or who do not experience issues with emotion regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of suicide among individuals with psychosis by improving their emotional regulation skills.
How similar studies have performed: Previous research has shown that interventions targeting emotion regulation, such as DBT, can be effective in reducing suicidality in other populations, although this specific approach in individuals with psychosis is relatively novel.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Phalen, Peter Lee — University of Maryland Baltimore
- Study coordinator: Phalen, Peter Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.